Atlas Trials

Study to Compare the Clinical and Radiological Efficacy of 625 mg Versus 1250 mg of Oral Methylprednisolone in Patients With Multiple Sclerosis in Relapse

Clinical trial NCT01986998 · COMPLETED

Trial details

NCT number
NCT01986998
Sponsor
Germans Trias i Pujol Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2013-10-01
Primary completion
2016-02-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.